Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Promisia Healthcare's Enterprise Value is NZ$161.23 Mil.
Promisia Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$17.51 Mil. Therefore, Promisia Healthcare's EV-to-EBIT ratio for today is 9.21.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Promisia Healthcare's Enterprise Value is NZ$161.23 Mil.
Promisia Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$18.02 Mil. Therefore, Promisia Healthcare's EV-to-EBITDA ratio for today is 8.95.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Promisia Healthcare's Enterprise Value is NZ$161.23 Mil.
Promisia Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$37.86 Mil. Therefore, Promisia Healthcare's EV-to-Revenue ratio for today is 4.26.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Promisia Healthcare (NZSE:PHL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$17.51 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$18.02 Mil.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$37.86 Mil.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$6.36 Mil.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$5.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare Enterprise Value Related Terms
Promisia Healthcare Enterprise Value Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:PHL vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Promisia Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Promisia Healthcare's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NZ$161.23 Mil mean?
Promisia Healthcare (NZSE:PHL) has a Enterprise Value of NZ$161.23 Mil as of Jul. 22, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Promisia Healthcare and its competitors.
Is Promisia Healthcare's Enterprise Value too high?
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's Enterprise Value compare to HCA and THC?
Promisia Healthcare's Enterprise Value of NZ$161.23 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Promisia Healthcare and its competitors. Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current Enterprise Value is NZ$161.23 Mil. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current Enterprise Value is NZ$161.23 Mil as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
Enterprise Value: NZ$161.23 Mil
GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score
Get the complete analysis for NZSE:PHL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
